Two Sigma Advisers’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-824,400
Closed -$2.56M 3029
2021
Q4
$2.56M Sell
824,400
-234,000
-22% -$787K 0.01% 1070
2021
Q3
$3.82M Buy
1,058,400
+234,300
+28% +$884K 0.01% 917
2021
Q2
$2.95M Sell
824,100
-11,800
-1% -$41.6K 0.01% 1109
2021
Q1
$3.27M Buy
835,900
+196,300
+31% +$811K 0.01% 1042
2020
Q4
$2.69M Sell
639,600
-454,300
-42% -$1.75M 0.01% 1108
2020
Q3
$4.08M Sell
1,093,900
-68,000
-6% -$289K 0.01% 840
2020
Q2
$5.07M Buy
1,161,900
+59,300
+5% +$267K 0.01% 789
2020
Q1
$4.18M Buy
1,102,600
+31,400
+3% +$154K 0.02% 778
2019
Q4
$6.77M Buy
1,071,200
+573,000
+115% +$3.37M 0.02% 726
2019
Q3
$2.1M Sell
498,200
-158,700
-24% -$678K 0.01% 1089
2019
Q2
$3.06M Buy
656,900
+451,100
+219% +$2.1M 0.01% 1021
2019
Q1
$1.09M Buy
+205,800
New +$940K ﹤0.01% 1487
2014
Q3
Sell
-14,100
Closed -$170K 2967
2014
Q2
$170K Buy
+14,100
New +$134K ﹤0.01% 2302
2014
Q1
Sell
-11,300
Closed -$67K 2756
2013
Q4
$67K Buy
+11,300
New +$58.2K ﹤0.01% 2234

Other funds holding BDSI

Two Sigma Advisers's BDSI Position: Q1 2022 in Review

Two Sigma Advisers sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 824,400 shares — an estimated $2.56M sold.

Two Sigma Advisers first reported a position in BDSI in Q4 2013 and held it in 14 quarters. The position peaked at $6.77M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Two Sigma Advisers reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 824,400 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $2.56M.
  • Two Sigma Advisers first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 14 quarters.
  • Two Sigma Advisers's BioDelivery Sciences International, Inc. position peaked at $6.77M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.